Status:
UNKNOWN
Plaque Registration and Event Detection In Computed Tomography
Lead Sponsor:
Hiroshima University
Conditions:
Atherosclerosis
Cardiovascular Diseases
Eligibility:
All Genders
20+ years
Brief Summary
Disruption of an atherosclerotic plaque is responsible for at least two-thirds of acute coronary syndrome. Thus, identification of plaques vulnerable to rupture has become important. The natural histo...
Eligibility Criteria
Inclusion
- patients with known or suspected coronary artery disease.
Exclusion
- irregular heart beat,
- known allergy towards the contrast agent,
- renal dysfunction,
- uncontrolled heart failure,
- previous coronary bypass surgery, or pacemaker or ICD implantation, ST elevation MI or unstable hemodynamic condition,
- impossible breath-hold, OR
- end-stage cancer.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
3015 Patients enrolled
Trial Details
Trial ID
NCT00991835
Start Date
October 1 2009
End Date
December 1 2014
Last Update
March 20 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hiroshima University Graduate School of Biomedical and Health Sciences, Department of Cardiovascular Medicine
Hiroshima, Hiroshima, Japan, 734-8551